In general, the effect of CD40 on tumorigenesis and response to therapy (sensitivity and toxicity) may largely depend on the context of the tumor type and cancer stage, cytokine availability, ligand/receptor distribution, and crosstalk among different stimuli, cell types, and signaling pathways. The gene discussed is CD40; the disease is cancer.